ICD-10-CM Billable Code

M11.039

Hydroxyapatite deposition disease, unspecified wrist

Clinical Classification Guidelines

Medical Intelligence & Overview

Hydroxyapatite deposition disease (HADD) in the wrist is a condition characterized by the accumulation of calcium phosphate crystals, specifically hydroxyapatite, in the soft tissues surrounding the joints. Although it is more common in the shoulder, it can also develop in the wrist, leading to pain, swelling, and limited mobility. The condition can sometimes be mistaken for other joint issues, making proper diagnosis essential for effective management.

Causes & Symptoms

Clinical Causes: Idiopathic factors: The exact cause of crystal formation remains unknown, but it may develop spontaneously without clear reasons. Degenerative changes: Wear and tear in the joint tissues can contribute to the abnormal deposition of calcium phosphate crystals. Trauma: Past injuries or repeated stress to the wrist area may predispose individuals to develop hydroxyapatite deposits. Age-related changes: The likelihood of crystal deposition increases with age, partially due to decreased tissue regeneration. Underlying metabolic conditions: Disorders that affect calcium and phosphate balance can potentially contribute, though their exact role in wrist HADD is not fully established.

Key Symptoms: Localized pain in the wrist, which can worsen with movement or pressure Swelling and tenderness around the affected joint Reduced range of motion, leading to stiffness Possible warmth or redness of the skin over the affected area Occasional crepitus or grinding sensation during wrist movement In some cases, asymptomatic deposits are discovered incidentally during imaging studies

Diagnostic & Treatment

Diagnosis Path: Diagnosing hydroxyapatite deposition disease involves a combination of clinical evaluation and imaging tests: - Physical examination to assess tenderness, swelling, and movement limitations. - X-rays: Often reveal calcified deposits in the soft tissues surrounding the wrist joint. - Ultrasound: Helpful in detecting deposits that are not visible on X-rays and can guide minimally invasive procedures. - MRI: Utilized in complex cases to assess associated tissue inflammation or damage. - Laboratory tests: Typically, blood tests are not diagnostic but can help rule out other metabolic disorders.

Treatment Protocols: Treatment options aim to reduce pain, decrease inflammation, and manage calcium deposits: - Rest and immobilization of the wrist to prevent further irritation. - Nonsteroidal anti-inflammatory drugs (NSAIDs): Such as ibuprofen or naproxen to alleviate pain and inflammation. - Corticosteroid injections: To provide targeted relief in persistent or severe cases. - Physical therapy: Exercises to maintain mobility and strengthen surrounding muscles. - Ultrasound-guided needle lavage: Procedures to remove calcium deposits directly. - Surgical removal: Considered in refractory cases where conservative treatments do not provide relief, especially if deposits significantly impair function. - Monitoring: Regular follow-up to observe the progression or resolution of deposits and symptoms.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M11.039 a billable ICD-10 code?
Yes, M11.039 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M11.039?
Clinical documentation must specify the nature of Hydroxyapatite deposition disease, unspecified wrist and any associated comorbidities for accurate reporting.

Cite this Clinical Reference